CAS 1052147-86-0
:4-[1,1′-Biphenyl]-2-yl-N-[(4-cyanophenyl)methyl]-1-piperazinehexanamide
Description:
4-[1,1′-Biphenyl]-2-yl-N-[(4-cyanophenyl)methyl]-1-piperazinehexanamide is a synthetic organic compound characterized by its complex structure, which includes a biphenyl moiety, a piperazine ring, and a hexanamide chain. This compound features multiple functional groups, including an amide and a cyanophenyl group, which contribute to its potential biological activity and solubility properties. The presence of the piperazine ring suggests possible interactions with biological targets, making it of interest in medicinal chemistry. Its molecular structure indicates that it may exhibit lipophilic characteristics due to the biphenyl and cyanophenyl groups, which could influence its pharmacokinetics and bioavailability. Additionally, the compound's specific stereochemistry and substituent positions can significantly affect its reactivity and interaction with other molecules. Overall, this compound may be explored for its potential applications in pharmaceuticals, particularly in the development of therapeutic agents targeting various biological pathways.
Formula:C30H34N4O
InChI:InChI=1S/C30H34N4O/c31-23-25-14-16-26(17-15-25)24-32-30(35)13-5-2-8-18-33-19-21-34(22-20-33)29-12-7-6-11-28(29)27-9-3-1-4-10-27/h1,3-4,6-7,9-12,14-17H,2,5,8,13,18-22,24H2,(H,32,35)
InChI key:InChIKey=BQEDZLDNNBDKDS-UHFFFAOYSA-N
SMILES:C(CCCCC(NCC1=CC=C(C#N)C=C1)=O)N2CCN(C3=C(C=CC=C3)C4=CC=CC=C4)CC2
Synonyms:- 1-Piperazinehexanamide, 4-[1,1′-biphenyl]-2-yl-N-[(4-cyanophenyl)methyl]-
- 4-[1,1′-Biphenyl]-2-yl-N-[(4-cyanophenyl)methyl]-1-piperazinehexanamide
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
LP-211
CAS:LP-211 is a brain penetrant selective agonist for a 5-HT7 receptor (Ki: 0.58 nM), and >300-fold selectivity over the 5-HT1A receptor.Formula:C30H34N4OPurity:98.65%Color and Shape:SolidMolecular weight:466.62LP-211
CAS:LP-211 is a drug that binds to the 5-hydroxytryptamine 7 receptor (5-HT7) with high affinity and specificity. It is a potent and selective antagonist of the 5-HT7 receptor, which has been shown to be involved in the regulation of brain functions, neurodevelopmental processes and locomotor activity. LP-211 also inhibits the binding of serotonin to its receptors, suggesting that it may have therapeutic potential for treating neuropsychiatric disorders such as depression or anxiety. LP-211 is an irreversible inhibitor of the 5-HT7 receptor, which blocks the activation of this receptor by serotonin. This drug also has pharmacokinetic properties that are suitable for oral administration.Formula:C30H34N4OPurity:Min. 95%Molecular weight:466.62 g/mol



